These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment. Koske I; Rössler A; Pipperger L; Petersson M; Barnstorf I; Kimpel J; Tripp CH; Stoitzner P; Bánki Z; von Laer D Int J Cancer; 2019 Oct; 145(7):1958-1969. PubMed ID: 30972741 [TBL] [Abstract][Full Text] [Related]
12. Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors. Qiao J; Wang H; Kottke T; Diaz RM; Willmon C; Hudacek A; Thompson J; Parato K; Bell J; Naik J; Chester J; Selby P; Harrington K; Melcher A; Vile RG Gene Ther; 2008 Apr; 15(8):604-16. PubMed ID: 18305577 [TBL] [Abstract][Full Text] [Related]
13. Systemic combination virotherapy for melanoma with tumor antigen-expressing vesicular stomatitis virus and adoptive T-cell transfer. Rommelfanger DM; Wongthida P; Diaz RM; Kaluza KM; Thompson JM; Kottke TJ; Vile RG Cancer Res; 2012 Sep; 72(18):4753-64. PubMed ID: 22836753 [TBL] [Abstract][Full Text] [Related]
14. Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses. Woller N; Gürlevik E; Fleischmann-Mundt B; Schumacher A; Knocke S; Kloos AM; Saborowski M; Geffers R; Manns MP; Wirth TC; Kubicka S; Kühnel F Mol Ther; 2015 Oct; 23(10):1630-40. PubMed ID: 26112079 [TBL] [Abstract][Full Text] [Related]
15. Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses. Rajani K; Parrish C; Kottke T; Thompson J; Zaidi S; Ilett L; Shim KG; Diaz RM; Pandha H; Harrington K; Coffey M; Melcher A; Vile R Mol Ther; 2016 Feb; 24(1):166-74. PubMed ID: 26310630 [TBL] [Abstract][Full Text] [Related]
16. Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy. Rojas JJ; Sampath P; Hou W; Thorne SH Clin Cancer Res; 2015 Dec; 21(24):5543-51. PubMed ID: 26187615 [TBL] [Abstract][Full Text] [Related]
17. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice. Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014 [TBL] [Abstract][Full Text] [Related]
18. Chimerization of the Anti-Viral CD8 Vile R; Webb M; van Vloten J; Evgin L; Sangsuwannukul T; Kendall B; Tonne J; Thompson J; Metko M; Moore M; Yerovi MC; McNiven M; Monga S; Borad M; Roberts L Res Sq; 2023 Nov; ():. PubMed ID: 38045348 [TBL] [Abstract][Full Text] [Related]
19. Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy. Blanchard M; Shim KG; Grams MP; Rajani K; Diaz RM; Furutani KM; Thompson J; Olivier KR; Park SS; Markovic SN; Pandha H; Melcher A; Harrington K; Zaidi S; Vile R Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):577-87. PubMed ID: 26461000 [TBL] [Abstract][Full Text] [Related]